These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 15142150

  • 21. Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials.
    Nijman RJ, Borgstein NG, Ellsworth P, Djurhuus JC.
    J Urol; 2005 Apr; 173(4):1334-9. PubMed ID: 15758796
    [Abstract] [Full Text] [Related]

  • 22. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
    Staskin DR, Dmochowski RR, Sand PK, Macdiarmid SA, Caramelli KE, Thomas H, Hoel G.
    J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423
    [Abstract] [Full Text] [Related]

  • 24. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 26. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P, Wormland RT, Möhring C, Goepel M.
    Neurourol Urodyn; 2009 Feb; 28(3):209-13. PubMed ID: 19205067
    [Abstract] [Full Text] [Related]

  • 27. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 28. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

  • 29. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome.
    Nitti VW, Dmochowski R, Sand PK, Forst HT, Haag-Molkenteller C, Massow U, Wang J, Brodsky M, Bavendam T.
    J Urol; 2007 Dec; 178(6):2488-94. PubMed ID: 17937959
    [Abstract] [Full Text] [Related]

  • 30. Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration.
    Wein AJ, Khullar V, Wang JT, Guan Z.
    BJU Int; 2007 Feb; 99(2):360-3. PubMed ID: 17155987
    [Abstract] [Full Text] [Related]

  • 31. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 32. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
    Wermeling DP, Grant GM, Lee A, Alexander N, Rudy AC.
    Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
    [Abstract] [Full Text] [Related]

  • 33. Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin.
    Fu FG, Lavery HJ, Wu DL.
    Neurourol Urodyn; 2011 Mar; 30(3):312-6. PubMed ID: 21305590
    [Abstract] [Full Text] [Related]

  • 34. Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome.
    Haab F, Cardozo L, Chapple C, Ridder AM, Solifenacin Study Group.
    Eur Urol; 2005 Mar; 47(3):376-84. PubMed ID: 15716204
    [Abstract] [Full Text] [Related]

  • 35. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N, Pong A, Newman K, MD-10 Study Group.
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [Abstract] [Full Text] [Related]

  • 36. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 37. Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial.
    Marschall-Kehrel D, Feustel C, Persson de Geeter C, Stehr M, Radmayr C, Sillén U, Strugala G.
    Eur Urol; 2009 Mar; 55(3):729-36. PubMed ID: 18502028
    [Abstract] [Full Text] [Related]

  • 38. A double-blind randomized controlled trial of electromagnetic stimulation of the pelvic floor vs sham therapy in the treatment of women with stress urinary incontinence.
    Gilling PJ, Wilson LC, Westenberg AM, McAllister WJ, Kennett KM, Frampton CM, Bell DF, Wrigley PM, Fraundorfer MR.
    BJU Int; 2009 May; 103(10):1386-90. PubMed ID: 19154474
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis.
    Bosma R, Wynia K, Havlíková E, De Keyser J, Middel B.
    Acta Neurol Scand; 2005 Jul; 112(1):1-5. PubMed ID: 15932348
    [Abstract] [Full Text] [Related]

  • 40. Terodiline in the treatment of urinary frequency and motor urge incontinence. A controlled multicentre trial.
    Peters D.
    Scand J Urol Nephrol Suppl; 1984 Jul; 87():21-33. PubMed ID: 6399953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.